Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:oragenics [2022/01/13 22:29]
liam [COVID-19]
+++ pharmaceutical_companies:oragenics [2024/11/11 18:35] (current)
liam [COVID-19]
@@ Line 13: / Line 13: @@
 Oragenics is developing an intranasal [[:COVID-19]] [[:vaccine]] product with [[BioDextris]].((Sullivan, M., & Golodetz, K. (2021, March 9). //Oragenics Enters into Material Transfer Agreement with Biodextris for Mucosal Adjuvant for Intranasal COVID-19 Vaccine.// Business Wire; Berkshire Hathaway. https://archive.ph/QrWCj))
-In December 2021, the company extended its licensing and collaboration agreement with the [[:National Research Council of Canada]] that "will enable Oragenics to pursue an intranasal vaccine designed to protect against the SARS-CoV-2 Omicron variant."((Sullivan, M. (2021, December 20). //Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant.// Www.oragenics.com. https://archive.ph/Q0nNC))
+In December 2021, the company extended its licensing and collaboration agreement with the [[:National Research Council of Canada]] that "will enable Oragenics to pursue an intranasal vaccine designed to protect against the SARS-CoV-2 Omicron variant."((Sullivan, M. (2021, December 20). //Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant.// Oragenics. https://archive.ph/Q0nNC))
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Oragenics|White Rose Wiki]]